Skip to content

Clinical Study of Saptaparna Bark in the Management of Tamaka-Shwasa (Bronchial Asthma)

Pharmacognostical study & clinical efficacy of Saptaparna ( Alstonia scholaris Linn.) on Tamaka shwasa w.s.r Bronchial Asthma - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080923
Enrollment
58
Registered
2025-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

None listed

Sponsors

Ayurvedic and Unani Tibbia College and Hospital karol bagh new delhi India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between the age group of 18 to 60 years of either sex present with clinical features of Tamaks Shwasa. Recurrent episodes of Wheezing,Breathlessness,Chest tightness and Coughing (particularly at night or in the morning). Mild persistent cases of tamaka shwasa of duration more than 1 month.i.e having night symptoms more than twice per month but less than once a week and FEV1 more than 80% of the predicted value.

Exclusion criteria

Exclusion criteria: Patients below 18 years and above 60 years will be excluded.Tuberculosis (pulmonary).Chronic obstructive pulmonary disease(COPD).Pleural effusion.Cardiac Asthma.Emphysema.Status Asthmaticus.Patients suffering from systemic disorders like renal failure,hypertension,Diabetes Mellitus etc.Pregnancy and lactating monther.

Design outcomes

Primary

MeasureTime frame
The expected primary outcome is improvement in the symptoms from tamaka shawsa baseline ( day 0) after 90 days of therapy.Timepoint: 3 month

Secondary

MeasureTime frame
The expected secondary outcome is the safety and efficacy of the therapy under investigation.At the end of the study, safety of drug can be noted with any side effect and four point global assessment scale for efficacy (excellent,good,satisfactory and poor)will be exmined.Timepoint: 3 month

Countries

India

Contacts

Public ContactDr Rajesh Sharma

Ayurvedic and Unani Tibbia college

rajsakshi.sharma@gmail.com9868092250

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026